Diabetes mellitus, koronare Herzkrankheit und Herzinsuffizienz (Update 2023)

Martin Clodi; Christoph H. Saely; Friedrich Hoppichler; Michael Resl; Clemens Steinwender; Harald Stingl; Thomas C. Wascher; Yvonne Winhofer; Harald Sourij

doi:10.1007/s00508-023-02183-7

Diabetes mellitus, koronare Herzkrankheit und Herzinsuffizienz (Update 2023)

Translated title of the contribution: Diabetes mellitus, coronary artery disease and heart disease (Update 2023)

Martin Clodi^*, Christoph H. Saely, Friedrich Hoppichler, Michael Resl, Clemens Steinwender, Harald Stingl, Thomas C. Wascher, Yvonne Winhofer, Harald Sourij

^*Corresponding author for this work

External Teachers

Research output: Journal article (peer-reviewed) › Journal article

1 Citation (Scopus)

Abstract

Diabetes mellitus, cardiovascular disease and heart failure are interacting dynamically. Patients being diagnosed with cardiovascular disease should be screened for diabetes mellitus. Enhanced cardiovascular risk stratification based on biomarkers, symptoms and classical risk factors should be performed in patients with preexisting diabetes mellitus. In patients with previously diagnosed arterosclerotic cardiovascular disease an agent proven to reduce major adverse cardiovascular events or cardiovascular mortality is recommended.

Translated title of the contribution	Diabetes mellitus, coronary artery disease and heart disease (Update 2023)
Original language	German
Pages (from-to)	201-206
Number of pages	6
Journal	Wiener Klinische Wochenschrift
Volume	135
DOIs	https://doi.org/10.1007/s00508-023-02183-7
Publication status	Published - Jan 2023

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/s00508-023-02183-7

Cite this

@article{537bce45c243478392e8a7a539b2b780,

title = "Diabetes mellitus, koronare Herzkrankheit und Herzinsuffizienz (Update 2023)",

abstract = "Diabetes mellitus, cardiovascular disease and heart failure are interacting dynamically. Patients being diagnosed with cardiovascular disease should be screened for diabetes mellitus. Enhanced cardiovascular risk stratification based on biomarkers, symptoms and classical risk factors should be performed in patients with preexisting diabetes mellitus. In patients with previously diagnosed arterosclerotic cardiovascular disease an agent proven to reduce major adverse cardiovascular events or cardiovascular mortality is recommended.",

keywords = "Coronary artery disease, Diabetes mellitus, Heart failure, Heart failure in diabetes, Screening",

author = "Martin Clodi and Saely, {Christoph H.} and Friedrich Hoppichler and Michael Resl and Clemens Steinwender and Harald Stingl and Wascher, {Thomas C.} and Yvonne Winhofer and Harald Sourij",

note = "Publisher Copyright: {\textcopyright} 2023, The Author(s).",

year = "2023",

month = jan,

doi = "10.1007/s00508-023-02183-7",

language = "Deutsch",

volume = "135",

pages = "201--206",

journal = "Wiener Klinische Wochenschrift",

issn = "0043-5325",

publisher = "Springer",

}

TY - JOUR

T1 - Diabetes mellitus, koronare Herzkrankheit und Herzinsuffizienz (Update 2023)

AU - Clodi, Martin

AU - Saely, Christoph H.

AU - Hoppichler, Friedrich

AU - Resl, Michael

AU - Steinwender, Clemens

AU - Stingl, Harald

AU - Wascher, Thomas C.

AU - Winhofer, Yvonne

AU - Sourij, Harald

PY - 2023/1

Y1 - 2023/1

N2 - Diabetes mellitus, cardiovascular disease and heart failure are interacting dynamically. Patients being diagnosed with cardiovascular disease should be screened for diabetes mellitus. Enhanced cardiovascular risk stratification based on biomarkers, symptoms and classical risk factors should be performed in patients with preexisting diabetes mellitus. In patients with previously diagnosed arterosclerotic cardiovascular disease an agent proven to reduce major adverse cardiovascular events or cardiovascular mortality is recommended.

AB - Diabetes mellitus, cardiovascular disease and heart failure are interacting dynamically. Patients being diagnosed with cardiovascular disease should be screened for diabetes mellitus. Enhanced cardiovascular risk stratification based on biomarkers, symptoms and classical risk factors should be performed in patients with preexisting diabetes mellitus. In patients with previously diagnosed arterosclerotic cardiovascular disease an agent proven to reduce major adverse cardiovascular events or cardiovascular mortality is recommended.

KW - Coronary artery disease

KW - Diabetes mellitus

KW - Heart failure

KW - Heart failure in diabetes

KW - Screening

UR - http://www.scopus.com/inward/record.url?scp=85153913954&partnerID=8YFLogxK

U2 - 10.1007/s00508-023-02183-7

DO - 10.1007/s00508-023-02183-7

M3 - Artikel in Fachzeitschrift

C2 - 37101042

AN - SCOPUS:85153913954

SN - 0043-5325

VL - 135

SP - 201

EP - 206

JO - Wiener Klinische Wochenschrift

JF - Wiener Klinische Wochenschrift

ER -

Diabetes mellitus, koronare Herzkrankheit und Herzinsuffizienz (Update 2023)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this